Abstract
At the request of the author, and with the agreement of the journal editors, the following article has been retracted and is re-published as open access in January 2022.
Song H-Y, Xia J-S, Chen Y-G, Chen L. (2021) Cytochrome P450 3A5 polymorphism affects the metabolism of sorafenib and its toxicity for hepatocellular carcinoma cells in vitro. Human and Experimental Toxicology 40(12S): S646–S653. DOI: 10.1177/09603271211052989